What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?

Table 1

The summary of outcomes of age, PSA, and SUV with prostate cancer using the Wilcoxon rank sum test.

	𝑁	Mean	Std	Min	Median	Max	𝑃 value
PSA
Prostate cancer
No	9	2.20	1.71	0.20	1.70	5.20	0.007
Yes	11	10.23	8.75	1.80	5.60	26.80
All	20	6.62	7.63	0.20	4.70	26.80
SUV
Prostate cancer
No	10	8.41	4.41	2.00	7.25	15.70	0.58
Yes	14	8.01	6.02	2.00	5.85	19.70
All	24	8.18	5.31	2.00	6.85	19.70
Age
Prostate cancer
No	11	71.20	8.44	57.08	71.84	81.62	0.80
Yes	15	72.73	10.07	53.00	74.00	90.00
All	26	72.08	9.27	53.00	73.50	90.00